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The regulation of lymphocyte function by antibodies specific for the antigenic
determinants of immunoglobulin molecules is well documented . In utero expo-
sure to antiallotypic or antiidiotypic antibodies induces a chronic suppression of
the corresponding allotype (1) or idiotype (Id)` (2, 3) . Similarly, the parenteral
administration after birth of antiisotypic, (,u or 6), antiallotypic, or antiidiotypic
antibodies can cause the suppression of synthesis of immunoglobulins (4, 5),
corresponding allotype (6), or Id (7), respectively . The parenteral administration
of antiidiotypic antibodies in adult animals has many effects . It can cause idiotyppc
suppression, elicit the production of anti-(antiidiotypic) antibodies, or prime, in
the absence of antigen, the Id-bearing B cell clones, the Id-bearing helperT cells
or suppressor T cells, andT cells that mediate delayed-type hypersensitivity or
contact sensitivity reactions (for a review see reference 8).
In previous studies we have shown that the administration of antiidiotypic
keyhole limpet hemocyanin (KLH) antibody conjugates, in complete Freund's
adjuvant, into adult BALB/c mice led to a substantial activation ofminor clones
(i.e ., M460 Id trinitrophenyl [TNP]-specific clones) (9), or silent clones (i.e ., A48
Id ,Q2 --~ 6 fructosan-specific clones) (10) . The expression of these clones, which
are associated with the Igha haplotype, can be obtained in various strainsof mice .
We have shown that M460 Id's clones can be activated in DBA/2 mice (Igh`) (11)
andthat the A48 Id' clones can be activated in CAL .20 (Igha), BAB.14 (IghV,Cb),
or CCB.R4 (IghVbC,) mouse strains (12) .
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ACTIVATION OF CLONES BY ANTIGEN AND HOMOBODY
Recently Kelsoe et al. (13) have reported that the administration, in saline, of
minute amounts of a monoclonal anti-(4-hydroxy-3-nitrophenyl) acetyl (NP)
idiotypec antibody (AC146) into C57BL/6 mice induced a 20-fold enhancement
of synthesis of the BI-8 idiotope borne by an anti-NP monoclonal antibody. Since
we did not succeed in activating the A48 Id' 02 --> 6 fructosan-reactive clones
by the injection of syngeneic anti-A48 Id antibodies in saline into adult mice, we
studied the effect of the administration of these antibodies after birth (14).
In this communication we present data that show that the administration at
birth of minute amounts of anti-A48 Id antibodies causes a long-lasting activation
of A48 Id' ,02 --~- 6 fructosan-specific clones . This activation requires antigenic
challenge (i .e ., immunization with bacterial levan [BL]), and antigenic challenge
can be replaced by a monoclonal anti-A48 Id antibody. This activation is related
to a T-independent expansion of anti-a2 ---> 6 fructosan B cell clones expressing
the A48 Id.
Materials and Methods
Animals.
￿
Normal BALB/c mice, 4-12-wk-old, were purchased from the Charles River
Breeding Laboratory, Wilmington, MA. 1-d-old BALB/c mice were bred in our colony
at the Mount Sinai School of Medicine. The recombinant inbred strain CXBJ was obtained
from The Jackson Laboratory, Bar Harbor, ME.
Antigens.
￿
BL was isolated by alcohol precipitation from culture supernates of Aerobacter
laeveiicura (ATCC15552) grown at 23 ° C in nutrient broth supplemented with 5-10%
sucrose. TNP-aminoethylcarbamyimethyl-Ficoll (TNP-Ficoll) was prepared as described
previously (15). Inulin (In) was obtained from Calbiochem-Behring Corp., American
Hoechst Corp., San Diego, CA .
,Vlyeloma Proteins. The BALB/c myeloma proteins used in this study were ABPC48
(A48), UPC10 (U10), W3082, and MOPC460 (M460); all are IgAK immunoglobulins
except U 10 which is IgG2a.. A48 and U 10 possess 02 -> 6 fructosan-binding activity and
lack the cross-reactive idiotype (IdX) of myeloma proteins that bind both BL and In, such
as W3082. M460 is a TNP-binding myeloma protein. These myeloma proteins were
kindly provided by Dr. Michael Potter, National Cancer Institute.
Preparation of Anti-Id Antibody.
￿
Anti-A48 Id antisera were prepared in BALB/c mice
by immunization with an A48-KLH conjugate. Anti-M460 Id, anti-U10 Id, and anti-
W3082 Id antisera were prepared in the same way . The method used for coupling
myeloma proteins to KLH as well as the schedule adopted for immunization, have been
described elsewhere (10). Several syngeneic monoclonal anti-A48 Id antibodies were
obtained from a fusion of immune lymphocytes from BALB/c mice immunized with A48
Id and the SP2/0 myeloma cell line.
Labeling of Sheep Erythrocytes (SRBC) with BL, Iii, and TNP.
￿
An 0-stearoyl derivative of
BL and In were prepared according to the method of Hammerling and Westphal (16).
Briefly, 1 ml of 10% SRBC, 3 ml saline, and 10 ml of the stearoyl derivative were added
together and incubated for 30 min at 37°C. This was followed by extensive washing with
saline before use in the hemolytic plaque assay . TNP was coupled to SRBC by the method
of Rittenberg and Pratt (17).
Detection ofPlayueforming Cells (PFC).
￿
The number of PFC secreting antibody specific
for BL, In, or TNP was determined by a technique in which spleen cells (50 u1) were
mixed at 45°C with 50 gl of 10% SRBC coated with BL, In, or TNP in 0.3 ml 0.5%
agarose and placed on slides. The slides were then incubated for 2 h at 37°C in the
presence of RPMI 1640 media; this was followed by a 1-h incubation at 37°C in the
presence of guinea pig complement diluted 1 :20 with Dulbecco's phosphate-buffered
saline . To determine the number of anti-BL PFC secreting antibody carrying A48, U 10,
and W3082 idiotypes, anti-In PFC carrying the W3082 Id, and anti-TNP PFC carrying
the M460 idiotype, anti-A48, anti-U10, anti-W3082, and anti-M460 antiserum in a finaldilution of 1 :10,000, 1 :5,000, 1 :100, and 1 :500, respectively, were added to the agarose
at the time of plating. The number of PFC observed in the presence of anti-Id was
subtracted from the number observed if no inhibitor was present. The difference was
considered to be the number of PFC secreting anti-BL, anti-In, or anti-TNP antibody
expressing the corresponding idiotypes.
Purification of T and B Cells. Purified splenic B lymphocytes were obtained from
BALB/c mice injected intraperitoneally with 0.1 ml rabbit anti-mouse thymocyte serum
(M.A. Bioproducts, Walkersville, MD) 2 d before beingsacrificed. The splenic lymphocytes
were harvested and treated with anti-Thy-1 .2 antisera plus complement to remove any
residual T cells. Purified splenic T lymphocytes were obtained in the following manner.
Plastic petri dishes (100 X 15 mm) were coated with 3 ml of rabbit anti-mouse immuno-
globulin serum (ammonium sulphate fraction, 1 mg/ml) for 1 h at 37°C. The plates were
then washed twice with phosphate-buffered saline, and 3 ml of a spleen cell suspension (5
X 107 cells) was added. Plates remained at room temperature for 1 h with gentle agitation
every 15 min. After 1 h, the nonadherent spleen cells were harvested from the plates.
Isoelectric Focusing (IEF).
￿
IEF was performed according to a method described in detail
previously (18).
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Requirement of Antigenic Challenge for the Activation of the A48 Id' Response in
BALB/c Mice Treated at Birth with Anti-A48 Id Antibodies. The A48 Id of a 02 --+
6 fructosan-binding myeloma protein, ABPC48, from the BALB/c mouse is not
expressed on antibodies of various mouse strains during a conventional immune
response after immunization with BL. However, the study of the anti-(32 -* 6
fructosan response in 1-mo-old BALB/c mice treated at birth with 0 .01-10 Ag
of anti-A48 Id antibodies demonstrated the appearance of A48 Id' anti-(32 --+ 6
fructosan PFC (Fig. 1). The percentage of A48 Id' PFC was significantly higher
in mice treated at birth with anti-A48 Id antibodies than in mice not so treated.
Results
DOSE OF
ANTI-A481d INJECTED ATBIRTH(Kg)
FIGURE 1 .
￿
Dose-effect relationship of treatment of newborn mice with various doses of anti-
A48 Id polyclonalantibody. Mice were 1 -d-old at the time of treatment and challenged 1 mo
later with 20 ng BL. (0) Anti-BL PFC/spleen; (0) anti-BL PFC/spleen detected when syngeneic
anti-A48 Id antisera had been added to the agarose. Shaded area represents the number of
PFC bearing the A48 Id. Each point represents the mean ± SEM of determinations performed
on five mice.1132
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The immunization with BL was critical for the activation, since mice treated at
birth with anti-A48 Id antibodies and not immunized with BL did not develop a
/32 --> 6 fructosan antibody response. Therefore, it appears that the administra-
tion at birth of anti-A48 Id antibodies was not sufficient by itself to activate A48
Id' anti-02 ---> 6 fructosan-specific clones, but must be supplemented with
antigenic challenge . It was previously demonstrated (14) that this activation is
Id-specific since the treatment with anti-A48 Id, but not the treatment with anti-
M384 Id, followed by immunization with BL I mo later, led to the activation of
A48 Id' clones (14). The M384 Id is borne on the MOPC384 myeloma protein
that binds a-methyl-D-galactoside, the immunodominant sugar shared on the
lipopolysaccharide of Salmonella tranaroa, Salmonella telaviv, and Proteus mirabilis
(19). Furthermore, BALB/c mice treated at birth with anti-A48 Id antibody and
immunized I mo later with TNP-Ficoll did not show a significant increase of the
A48 Id' component of the anti-,02 --3. 6 fructosan response, nor of the M460 Id'
component of the anti-TNP response (Table I). Therefore, the effect produced
by anti-A48 Id antibodies is specific, since treatment with anti-A48 Id did not
alter the M460 Id' component of the anti-TNP response.
Long-lasting Activation of Precursors of A48 Id' Antibody-Producing Cells After
Treatment at Birth with A)?ti-A48 Id Antibodies. The persistence of activation of
A48 Id'-bearing clones after treatment of mice at birth with 0 .01 and 10'ag of
anti-A48 Id antibodies, was studied in BALB/c mice immunized at various ages.
In these experiments the BALB/c mice after treatment at birth were immunized
with 20 tag of BL at either 4, 6, 8, or 12 wk and their anti-BL PFC response was
treasured 5 d later. The data depicted in Table II shows that the A48 Id+
component represents an insignificant fraction varying between 6 and 18% of
the anti-BL response in 4-12-wk-old BALB/c mice. The A48 Id+ component
significantly increases (35-79%) in mice treated at birth with 0.01 or 10 tag of
anti-A48 Id antibodies and challenged with the antigen, BL. Although the
TABLE I
Requirement ofAntigenfor the Activation of the A48 Id+ Response in BALB/c Mice Treated at
Birth with Anti-A48 Id Awibodj,
* Total anti-BL PFC/spleen response was measured 5 d after immunization. The percentage of A48
Id' anti-BL PFC was determined by the addition of anti-A48 Id antisera to the agarose and scoring
the difference in the number of PFC without antisera. Results represent the mean ± SEM for the
data obtained from five mice .
$ Total anti-TNP PFC/spleen response was measured 5 d after immunization. The percentage of
M460 Id' anti-TNP PFC was determined by the addition of anti-M460 Id antisera to the agarose
and scoring the difference in the number of PFC without antisera. Results represent the mean ±
SEM for the data obtained from five mice.
§ Not determined, insufficient number of plaques.
Mice treated at
birth with :
Mice challenged
with:
Anti-BL PFC/spleen*
Total A48Id+
Anti-TNP PFC/spleen$
Total M460 I&
Nil 20 ug BL 2,180 ± 513 6 ± 3 <100 ND§
Nil 20 tag TNP-Ficoll <100 ND 44,800 ± 3,582 16 ± 7
0.01 mg anti-A48 Id Nil <100 ND <100 ND
0.01 ug anti-A48 Id 20 wg 111, 2,920 ± 718 52 ± 7 <100 ND
0.01 ttg anti-A48 Id 20 jug TNP-Ficoll <100 ND 39,700 ± 7,860 24 ± 6TABLE II
Long-lasting Activation ofthe A48Id' Response After Treatmentat Birth with Anti-A48 Id
Antibody
Age of
mice
when im-
munized
RUBINSTEIN ET AL.
PFC/spleen after treatment at birth with:*
Nil
￿
0.01 wg anti-A48 Id
* Mean ± SEM for PFC/spleen detected for five mice, 5 dafter immunization.
TABLE III
Ability of 17-38 Monoclonal Anti-A48 Id Antibody to Elicit an Anti-
BL PFCResponse inn Mice Treated at Birth with 0.01 tag ofAnti-A48
Id Antibody
10 ug anti-A48 Id
* Each mouse received a 10 tag injection of the appropriate monoclonal
anti-A48 Id antibody and the anti-BL PFC response was measured 5 d
litter. Results are expressed as the mean for two mice.
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W3082 IdX anti-#2 ---> 6 and 02 --* I fructosan-reactive clones become dominant
in 6-wk-old mice (20) an A48 Id' anti-02 ---> 6 fructosan response was still
observed in 6-12-wk-old mice treatedat birth with anti-A48 Id antibodies. Thus,
the administration at birth of anti-A48 Id antibodies has a profound effect on B
cell precursors because it causes a long-lasting activation during postnatal life .
A Monoclonal Anti-A48 Id Antibody Is Able to Replace the Antigenic Challenge
Required for the Activation of on Anti-,82 -* 6 Fructoson Response. The previous
experiments demonstrated that antigenic challenge with BL was critical for the
differentiation of A48 Id'anti-/32 - *6 fructosan precursors. In apilot experiment
we screened several syngeneic monoclonal anti-A48 Id antibodies for theirability
to elicit an anti-/32 -> 6 fructosan PFC response in mice treated at birth with
polyclonal anti-A48 Id. These monoclonal antibodies recognize shared idiotopes
on A48 and U 10 monoclonal proteins (Goldberg et al., manuscript in prepara-
tion). The results depicted in Table III show that the injection of 10 ,ug of 17-
38 monoclonal antibody instead of BL 1 mo after the treatment at birth with
polyclonal anti-A48 Id antibodies induced a significant anti-BL PFC response.
Monoclonal anti-A48 Id antibodies, including 17-38, did not inhibit any partic-
with 20
ag BL
Total A48Id+ Total A48 1d+ Total A48 Id'
wk % %
4 2,180 ± 513 6 ± 3 2,920 ± 718 52 ± 7 688 ± 85 39 ± 13
6 1,300 ± 120 14 ± 2 675 ± 196 79 ± 10 2,387 ± 950 53 ± 9
8 6,270 ± 480 18 ± 9 3,362 ± 2,234 46 ± 13 6,175 ± 1,561 49 ± 5
12 13,140 ± 5,125 11 ± 3 9,150 ± 2,850 47 ± 12 13,490 ± 3,054 35 ± 8
Monoclonal anti-A48 Id
antibody* Isotype Anti-BL
PFC/spleen
26-125 IgGI 180
148-3 IgG1 140
100-105 IgG2b 180
23-113 IgM 120
14-114 IgM 40
17-38 IgM 2,1201134
￿
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ular property with respect to their ability to bind labeled A48 or anti-(anti-A48
Id) antibodies. In addition, the binding of labeled A48 to these monoclonal Ab2
was inhibited by BL (0.01-0.1 Ag/ml) (data not shown) . This "antigen-like" effect
was obtained with various concentrations (1, 10, 100 ,ug) of 17-38 monoclonal
antibodies (Fig. 2). In further experiments we studied the activation of both 02
--> 6 and 02 -4 1 fructosan-reactive clones in mice treated at birth with anti-A48
Id antibodies or BL and challenged 1 and 3 mo later with 1 ug of 17-38
monoclonal antibody. The rationale of this experiment followed our previous
observation, that there was a substantial ontogenic delay of the anti-02 -~ 1
fructosan antibody response (20). The results depicted in Table IV show that
BALB/c mice treated at birth with anti-A48 Id antibodies or BL and challenged
1 mo later with 17-38 monoclonal antibody develop only an A48 Id- anti-BL
response. It should be noted that only a U 10 Id' anti-BL response was observed
in mice treated at birth with BL and injected 1 mo later with 17-38. By contrast,
in mice challenged with BL, ^-50% of the anti-02 --> 6 fructosan PFC expressed
the A48 Id. Furthermore, the mice treated at birth with anti-A48 Id antibodies
and challenged 3 mo later with 17-38 monoclonal antibody developed an anti-
02 --> 6 and anti-02 -4 1 fructosan response expressing the dominant W3082
IdX. W3082 monoclonal protein shares IdX G, B, and A of E109 andJ606 In-
binding monoclonal proteins (3, 21). 1-mo- and 3-mo-old BALB/c mice not
treated at birth with anti-A48 Id antibodies and injected with 1 tag 17-38
monoclonal antibody did not develop an anti-02 ~ 6 or anti-02 ----> 1 fructosan
PFC response (data not shown). In addition, in both groups of mice the anti-
TNP PFC response and M460 Id' component were not augmented in the mice
treated at birth with anti-A48 Id antibodies and challenged 1 or 3 mo later with
17-38 monoclonal antibodies.
Analysis ofIgG Antibodies bi, IEF.
￿
Sera from 1- and 3-mo-old mice treated or
not at birth with anti-A48 Id antibodies and challenged with BL or 17-38 were
analyzed by IEF with '25I-In-bovine serum albumin (BSA) and '25I-BL. In the
sera of three individual 1-mo-old BALB/c [nice immunized with BL, a set of
faint bands that bound BL and focused between pH 7 and 8.2 were observed
Iz
DOSE OF
17-38 MONOCLONAL ANTIBODY (Ag)
FIGURE 2.
￿
Dose-effect relationship of the challenge with various doses of 17-38 monoclonal
anti-A48 Id antibodies. Mice were I -d-old at the time of treatment with 10 ng polyclonal anti-
A48 Id antibody and were challenged I nto later with various doses of 17-38 monoclonal
anti-A48 Id antibody. (0) Anti-BL PFC/spleen; (O) anti-BL PFC/spleen of mice treated at
birth with anti-A48 Id antibody and challenged I mo later with 20 kag BL; (A) anti-BL PFC/
spleen of normal mice challenged with 20 ag BL at I mo of age. Each point represents the
mean of determinations performed on two mice.RUBINSTEIN ET AL . 1135
TABLE IV
Age Dependence and the Specificity ofActivation ofAnti-/32 --* 6 and Anti-,82 - * I Fructosan Clones in
BALB/c,lice Treated at Birth with 0.01 jig Anti-A48 Id Antibody and Challenged with 17-38
Monoclonal Antibody
\lice were cleallenge(I with either 20 kg Bl ., 20 Ag'I'NI'-Ficoll, or ],.g]7-38 .
# All 1'F'( . results are expressed as the mean ± SEM . -I'll, percentage of Id* PFC in each group were detected by plaque inhibition experiments
i,I,orporaIing the appropriate antisera and scoring the difference in the number ofplaques vs . the total .
4 Not determined, insufficient number of plaques .
1 Mice were Inununized at birth with 10 Ag BL.
a Experiment not Iterfornu"d .
FIGURE 3 .
￿
10 Itl of serum from individual, 1-mo-old BALB/c mice were analyzed by IEF
autoradiography using '251-BL antigen overlay . The groups are indicatedabove the autoradi-
ogram and the individual sera are indicated by the numbers within each group . 10 Jul of a 1
mg/ml solution of U10 and J606 purified myeloma proteins were applied to the gel for
reference . Autoradiograms were obtained by exposing the film for 8-10 d .
Mice treated Challenged Age of
Anti-131 . PF(./spleen# Anti-In PFC/spleen Anti-TNP PFC/spleen
at birth with : with :* mice Tonal A48 Id* U10Id`
W3082
Total
W3082
Total
M460
IdX* IdX* Id*
Nil BI .
wo
1 2,850±824 14- 7 29- 16 76±9 <100 NDI <100 ND
Nil TN P-Ficoll I <100 ND ND ND <100 ND 48,600±6,713 I-1
B!! Nil I <100 ND ND ND <100 ND <I00 ND
Anti-A48 Nil 1 <100 ND ND ND <100 ND <I00 ND
Id
BL BI . 1 4,100-2,800 5-5 14-14 23±23 <100 ND <100 ND
Atni-A48 BI . 1 2,920±718 52±7 NP NP" <100 ND <100 ND
Id
BI . 17-38 1 1,750-310 0 33-1 30±3 310±70 0 <100 ND
Anti-A48 17-38 1 1,815±225 7±7 8-6 49-13 <100 ND <100 ND
Id
Nil Bl . 3 15,417±5,140 15-10 34±6 57±24 3,400±1,588 85-9 <100 ND
Nil 'I NP-Ficoll 3 <100 ND ND ND <100 ND 97,300± 18,631 0
Atni-A48 Nil 3 <100 ND ND ND <100 ND <100 ND
Id
Aini-A48 Bl . 3 9,150±2,850 47±12 NP NP NP NP <100 ND
Id
Anti-A48 17-38 3 6.750- 3,384 0 14 t 7 78 - 9 5,250- 2,905 76 ± 5 925 ± 364 28 ± 24
Id113 6
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(Fig . 3) . The dark curved bands seen in this group and in two of the three sera
in the anti-A48 plus -BL group that focus between pH 6 .8 and 7 .2, are nonspecific
and are due to the fact that these sera were highly hemolyzed . The bands
focusing between pH 7 and 8.2 correspond to the major anti-BL spectrotype
described previously in adult BALB/c mice (18) . An additional spectrotype, also
described, can be seen in serum I in this group . These spectrotypes were not
observed in sera of mice treated at birth with anti-A48 Id antibodies and
immunized 1 mo later with BL . Some BL binding was seen, however, in the
region between pH 5.7 and 6 .2 . These antibodies and U 10, which also focused
in this region and was poorly resolved, were specific for BL . All the mice treated
at birth with anti-A48 Id antibodies and challenged 1 mo later with 17-38
produced an IgG anti-BL response consisting of five spectrotypes focusing
between pH 7 and 8.5 (Fig . 3) . Again, these spectrotypes were the same as those
previously shown in the sera of adult BALB/c mice immunized with BL . No IgG
anti-In antibodies were detected in the sera of 1-mo-old mice in all three groups
(data not shown) . The sera of 3-mo-old normal mice immunized with BL showed
the characteristic BALB/c anti-In spectrotype shown previously (18) (Fig . 4) .
This spectrotype has the same focusing pattern as J606 (i.e ., an In-binding
myeloma protein of the IgG3 subclass) . This spectrotype was also observed (Fig .
4) in three mice treated at birth with anti-A48 Id antibodies and immunized 3
mo later with BL . However, BL binding showed that this spectrotype in the sera
from anti-A48 Id-treated mice bound better to BL than to In (Fig . 5) .
We have previously reported (18) that the recombinant inbred strain, CXBJ,
also has the characteristic BALB/c anti-In spectrotype . We report here that this
spectrotype in both CXBJ and BALB/c sera is indistinguishable from that of the
J606 myeloma (Fig . 6) . We have observed, however, that late in the response
after a single immunization with BL, this spectrotype shows preferential binding
to BL rather than In in sera from CXBJ mice (Fig . 7), but not in sera from
BALB/c mice (18) . We have also reported (22) that adult CXBJ mice, but not
adult BALB/c mice, after treatment with anti-E109 (anti-IdX)and immunization
FIGURE 4.
￿
10 p.1 of serum from individual, 3-mo-old BALB/c mice were analyzed by IEF
autoradiography using a . . .I-BL antigen overlay. The groups are indicated above the autora-
diogram and the individual sera are indicated by the numbers within each group . 10 pl of a 1
mg/ml solution of U10 and J606 purified myeloma proteins were applied to the gel for
reference . Autoradiograms were obtained by exposing the film for 8-10 d .RUBINSTEIN ET AL .
FIGURE 5 .
￿
10 pI of thesame sera from the individual, 3-mo-old BALB/c mice, as were shown
in Fig. 4, were analyzed using a ' 25I-In-BSA overlay . The groups are indicated above the
autoradiogram and the individual sera are indicated by the numbers within each group . 10 Al
ofa I mg/ml solution ofU10 andJ606 purified myeloma proteins were applied to the gel for
reference. Autoradiograms were obtained by exposing the film for 8-10 d .
FIGURE 6 .
￿
10 jl of serum obtained from individual CXBJ and BALB/c mice 10 d after
intravenous immunization with 20 wg BL were focused and overlaid with ",,I-In-BSA . 10 Al
of a I mg/ml solution ofJ606 were applied for reference .
FIGURE 7 .
￿
10 jI of serum from an individual CXBJ mouse obtained before immunization or
5, 10, 20, 40, and 60 d after intravenous immunization with 20 jug BL, were focused in
triplicate and each of the three panels was overlaid with radioactive antigen as indicated .
11371138
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with BL, express A48 anti-BL. These data taken together suggest that the
BALB/c anti-In spectrotype is comprised of two antibody clones, one of which
preferentially binds BL rather than In and which may bear the A48 Id. In the
sera of BALB/c mice treated at birth with anti-A48 Id and immunized at 3 mo
of age with BL, we observed anti-BL antibody spectrotypes characteristic of
normal BALB/c mice (Fig. 5). The sera of mice treated at birth with anti-A48
Id antibodies and challenged 3 mo later with 17-38, showed typical BALB/c In
and BL spectrotypes when present. Therefore, the PFC and IEF data showed
important alterations in the expression of anti-BL and -In clones in animals
treated at birth with anti-A48 Id antibodies and immunized later with BL or 17-
38.
T Independence of the Activation of A48 Id' Clones After Treatment at Birth with
Anti-A48Id Antibodies. In further experiments we investigated the requirement
of T cells for the A48 Id' response. Thus, highly purified T and B cells from
normal mice and mice treated at birth with anti-A48 Id antibodies were infused
alone or in different combinations into lethally irradiated BALB/c mice. The
mice were immunized with 20 Ag BL at the time ofcell transfer and the anti-BL
PFC response was measured 5 d later. The data depicted in Table V show that
the transfer of B cells from 1-mo-old animals treated at birth with anti-A48 Id
antibodies into lethally irradiated BALB/c mice, followed by immunization with
BL, was sufficient to obtain an A48 Id' PFC response. The infusion of B cells
together with Tcells from either normal animals or animals treated at birth with
anti-A48 Idantibodies into lethally irradiated BALB/c mice, did not significantly
alter the expression ofA48 Id' clones. Furthermore, the infusion ofB cells from
normal animals along with T cells from animals treated at birth with anti-A48
Id antibodies, did not elicit an A48 Id' response. Therefore, theseresults suggest
TABLE V
Transfer ofA48 Id' Response with B Cellsfont Mice Treated at Birth
with 0.01 jug of Anti-A48Id Antibody
* 40 X 106 B cells isolated from either normal BALB/c mice or BALB/c
mice treated at birth with 0.01 Eeg anti-A48 Id.
$ 20 X 106 T cells isolated from either normal BALB/c or BALB/c mice
treated at birth with 0.01 gg anti-A48 Id.
Anti-BL PFC response was assayed 5 d after the infusion of B and/or T
cells along with 20 jug BL. The percentage of A48 Id+ PFC was
determined by adding anti-A48 Id antisera into the agarose andscoring
the difference in the number of plaques vs. the total response. Results
are expressed as the mean ± SEM for the number of mice indicated.
Lethally irradiated BALB/
c mice infused with :
B cells* T cells*
Number of
mice
Anti-BL PFC/spleen§
Total A48 Id+
Nil Nil 2 180 ± 170 7 ± 7
Normal Nil 2 843 ± 375 0
Anti-A48 Nil 7 1,857 ± 964 46 ± 14
Normal Anti-A48 3 940 ± 530 0
Anti-A48 Normal 7 1,094 ± 449 42 ± 11
Anti-A48 Anti-A48 2 650 ± 75 28 ± 6RUBINSTEIN ET AL.
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that there is a direct interaction ofanti-A48 Id antibodies with the immunoglob-
ulin receptor of A48 Id' B cell precursors, which is responsible for their
activation.
Discussion
Immunization of BALB/c mice with BL, a 02 --> 6 polyfructosan with X32 -* 1
branch points, leads to a vigorous T-independent antibody response (23). Two
families of clones are involved in this response. The first family of clones is
specific for the 02 -i 6 fructosan linkage and does not express the Id ofA48 and
U 10 myeloma proteins that are specific for the 02 -). 6 linkage. An A48 Id'
response was detected only CXBJ recombinant inbred strains of mice, among
the various strains that were investigated (22). The synthesis of anti-#2 ---> 6
fructosan antibodies is independent ofIghC genes and occurs early in ontogeny
(20). The second family of clones produces antibodies specific for 02 -* 1
fructosan linkages (21). These antibodies share the IdX G, B, and A of In-
binding myeloma proteins. The expression of IdX is associated with the IghC"
allotype. The clones producing these antibodies belong to the Lyb-5' subset and
appear late in development (20).
In previous studies we have shown that A48 Id' 02 ---> 6 fructosan-specific
clones can be activated in nude and recombinant inbred CXBJ mice (22), after
administration at birth of A48 Id monoclonal protein (24), or in adult animals
producing anti-(anti-A48 Id) antibodies (10). These results clearly show that
antigen, idiotypic, or antiidiotypic antibodies can have a similar effect, leading
to the expansion of cells bearing the corresponding Id. This suggests that the
delicate balance between idiotypic and antiidiotypic clones that characterize the
steady state network can be perturbed by antigen, idiotypic or antiidiotypic
antibodies.
In this communication we present further results ofthe effect ofthe adminis-
tration at birth ofminute amounts ofanti-A48 Id antibodies on the activation of
normally silent A48 Id' anti-BL B cells. The priming at birth with minute
amounts of antiidiotypic antibodies has a long-lasting effect, since an A48 Id's
response was observed even in 12-wk-old mice. The long-lasting effect is not
related to the persistence of antiidiotypic antibodies . Radiolabelled monoclonal
proteins injected at birth are completely cleared from the blood by 30 d (24).
The transfer of an A48 Id' response with highly purified B cells from mice
treated at birth with anti-A48 Id antibodies and then infused into lethally
irradiated mice, suggests that the activation of precursors of A48 Id' secreting
cells is T-independent under these conditions. It might be envisioned that the
interaction of anti-A48 Id antibodies with cellular receptors bearing the A48 Id
mimics the binding of a T-independent antigen to a B cell receptor, and that in
the absence of T cell help leads to the activation of that B cell. In a general
sense, globular proteins such as a mouse immunoglobulin bearing a combining
site with antiidiotypic specificity is very likely to behave as a "thymus-independ-
ent" antigen.
Although the anti-A48 Id antibodies can prime, independently ofTcell help,
the A48 Id-bearing precursors, their effect is not related to a mitogen-like effect.
No anti-02 -+ 6 fructosan response was observed in BALB/c mice treated at1140
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birth with anti-A48 Id antibodies that were not challenged with BL or that were
challenged with TNP-Ficoll . In several experimental systems it was clearly shown
that the enhancement of the Id response after the administration of Id (13, 24,
25) or anti-Id antibodies (9, 10, 13) requires antigenic challenge.
The most striking observation in our study was the ability of a monoclonal
anti-A48 Id antibody to elicit an anti-BL response in mice treated at birth with
either polyclonal anti-A48 Id antibodies or BL. Such mice do not develop an
anti-BL response without antigen or anti-Id challenge. The results of PFC and
IEF summarized in Table VI show that whereas BL-immunized 1-mo-old mice
develop only an anti-02 ---> 6 fructosan response lacking A48 and U10 Id and
exhibiting typical BALB/c spectrotypes, the 3-mo-old mice developed a vigorous
anti-,Q2 1 and ,02 -> 6 fructosan response, expressed the W3082 IdX, and
exhibited a typical BALB/c anti-BL spectrotype andanti-InJ606-like spectrotype.
The administration at birth of minute amounts of anti-A48 Id antibodies pro-
foundly altered the clonal expression . Thus, the challenge with BL of 1-mo-old
mice led to the activation of A48 and U10 Id' anti-BL clones which correspond
to a U 10-like spectrotype. Furthermore, immunization with BL of 3-mo-old mice
still led to the activation of A48 and U10 Id anti-BL clones, but the product of
these clones corresponds to a spectrotype that was observed in CXBJ mice, the
single strain that developed an A48 Id' response (22) . CXBJ spectrotype is
characterized by five bands focusing in the same region as J606 but binds BL
rather than In .
The challenge with 17-38 monoclonal anti-A48 Id antibody of mice treated
at birth with anti-A48 Id antibodies or BL presented a completely different
picture. In 1-mo-old mice the anti-BL antibodies failed to express the A48 and
U10 Id and the spectrotype is of the type found in adult BALB/c mice. In 3-mo-
old mice, in addition to an A48 Id- and U10 Id- anti-BL response, a vigorous
In W3082 Id' PFC response was observed . These responses correspond to a
TABLE VI
Sunnnar.), Results ofPFC and IEF in Mice Treated at Birth with Anti-A48 Id and Challenged
with BL or 17-38
* Not determined.
Treatment
at birth
Chal-
lenged
with:
Age
of
mice BL A48
Id
PFC
U10
Id+
response
In W3082Id+
IEF pattern
(spectrotype)
BL In
1110
Nil BL 1 + - - - - BALB/c
Anti-A48 Id BL 1 + + ND* - - U10-like
Anti-A48 Id 17-38 1 + - - - - BALB/c
Nil BL 3 + - ± + + BALB/c BALB/c
J606
Anti-A48 Id BL 3 + + ND ND ND BALB/c and CXBJ
CXBJ
Anti-A48 Id 17-38 3 + - ± + + BALB/c BALB/c
J606RUBINSTEIN ET AL.
￿
1141
BALB/c BL spectrotype and In J606 spectrotypes as seen in normal 3-mo-old
mice. These findings indicate that:
(a) the challenge with antigen can be replaced by one out of six monoclonal
anti-A48 Id antibodies, clearly demonstrating that not all anti-A48 Id antibodies
exhibit antigen-like properties . The ability of 17-38 monoclonal antibody to
stimulate anti-(32 ----> 6 and 02 --* 1 clones can not be related to a particular
isotype or its avidity since other IgM monoclonal anti-A48 Id antibodies lack this
property. The pentameric structure ofIgM confers a high avidity to the antibod-
ies belonging to this class of immunoglobulin; and (b) there is a fundamental
difference between the challenge with antigen and the challenge with 17-38
monoclonal antibody. Whereas the challenge with antigen led to the activation
ofA48 and U 10 Id' component of the anti-BL response (^-50% in 1- and 3-mo-
old mice), the challenge with 17-38 monoclonal antibody led to the suppression
of A48 and U10 Id' clones and to the activation of A48 Id- anti-02 --). 6
fructosan-reactive clones in 1-mo-old mice. In 3-mo-old mice there was an
activation of W3082 IdX' anti-,Q2 -* 6 and 02 ~ 1 fructosan-reactive clones.
One possible explanation of the "antigen-like" property of this monoclonal
antibody, is that it actually represents a homobody (26), i.e., an anti-Id antibody
carrying the internal image of the antigen.
Anti-Id antibodies carrying the internal images ofthe antigens (i.e., homobod-
ies) were reported in several systems. The majority of the studies, carried out on
homobodies, were focused on their ability to inhibit the binding ofantigen to its
corresponding receptor (e.g., insulin, 27; retinol, 28; catecholamine, 29; formyl
peptide, 30; reovirus hemagglutimn, 31 ; murine antiidiotypicantibody displaying
anti-human y-globulin activity, 32) or to mimic the antigen effects after the
bindingofhomobodies to the "antigen cell receptor" (e.g., insulin, 27; alprenolol,
29). However, it is obvious that homobodies like all anti-Id antibodies (Ab2 =
p2i2) exhibit two functions, because through their paratopes (p2), they can bind
to clones bearing the corresponding Id and through their Id (i2), they can
stimulate other clones. We were fortunate that in our system we were able to
analyze these two functions of 17-38 anti-A48 Id monoclonal antibody, since
the administration at birth of minute amounts ofanti-A48 Id antibodies induces
a long-lasting activation of A48 Id' anti-02 --> 6 fructosan-reactive clones and
the natural ontogenic delay of the expression of W3082 IdX anti-02 ---> 6 and
02 --> i fructosan-reactive clones.
Results suggest that through its idiotype(s) (i2), the 17-38 monoclonal antibody
activated the proliferation of A48 Id- or W3082 IdX+ clones (Ab, = p,
ai,a [Ab,
antibody; p, paratope; i, idiotope]) and through its paratope occluded the
expression of A48 Id' clones (Ab, = p,bi,b) (Fig. 8). Recently Jerne et al. (33)
classified anti-Id antibodies into two categories: Ab2,, the anti-Id antibodies
directed against the conventional idiotopes ofAb,, and Ab2, 3, the anti-Id antibod-
ies carryingthe internal image oftheantigen. Our results show thata monoclonal
anti-Id antibody carrying the internal image of the antigen is bifunctional
because, by its paratope, it interacts with the immunoglobulin receptor ofclones
bearing the corresponding Id and by its idiotope can interact with the immuno-
globulin receptor of clones expressing unrelated idiotypes. No available data
exists on the structural correlates of the homobodies . It is very likely that the1142
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FIGURE 8 .
￿
Functional dualism of a homobody . Ab, antibody ; p, paratope ; i, idiotope; e,
epitope .
internal images are only putative copies (i.e ., topochemical copies) of the antigen,
a product of steric resemblance and not of identity in amino acid sequence .
Crystallographic studies of Fab fragments of several anti-A48 Id monoclonal
antibodies (including 17-38) will shed light on the shapes of variable regions of
antibodies that mimic the antigen .
Summary
The anti-02 --> 6 fructosan antibodies sharing the idiotypes (Id) of ABPC48
(A48) monoclonal protein represent a silent fraction of the anti-02 --* 6 fructosan
repertoire, since these antibodies cannot be detected during a conventional
immune response elicited by bacterial levan (BL) . However, the administration
at birth of minute amounts of anti-A48 Id antibodies causes a long-lasting
activation of A48 Id'-bearing clones . This activation is related to direct interac-
tion of anti-A48 Id antibodies with precursors bearing the A48 Id' immunoglob-
ulin receptor, since an A48 Id' response can be transferred with highly purified
B cells in lethally irradiated mice . The maturation of these precursors into A48
Id' anti-,M --, 6 fructosan antibody-secreting cells requires challenge by the
antigen . Isoelectric focusing (IEF) data showed that in 1-mo-old mice an UPCIO
(U 10)-like spectrotype was observed, whereas in 3-mo-old mice, a new spectro-
type binding BL rather than inulin (In) was identified . This spectrotype was
observed only in CXBJ mice, the single strain in which an A48 Id' response was
observed . The antigenic challenge can be replaced by a monoclonal anti-A48 Id
antibody (i .e ., 17-38) . Interestingly, in 1-mo-old BALB/c mice treated with anti-
A48 Id antibodies, the challenge with 17-38 monoclonal antibody led to the
activation of A48 Id- anti-02 --> 6 fructosan-reactive clones with BALB/c type
IEF spectrotypes, whereas in 3-mo-old BALB/c mice treated with anti-A48 Id
antibodies, the challenge with 17-38 monoclonal antibody led to the activation
of W3082 IdX+ anti-02 -~ 6 and 02 --> 1 fructosan-reactive clones . In these
animals, inhibition of A48 Id' anti-02 -~ 6 fructosan clones was observed . This
antibody probably represents a homobody carrying the internal image of the
antigen, which through its paratope suppresses theA48 Id' response and throughRUBINSTEIN ET AL.
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its Id activates an A48 Id- anti-#2 -)- 6 fructosan response in 1-mo-old mice and
in 3-mo-old mice leads to an anti-,02 -+ 6 and a2 --+ 1 fructosan response
dominated by the W3082 IdX. These differences are related to the natural
ontogenic delay of the development of W3082 IdX anti-,Q2 -* 6 and a2 --> 1
fructosan clones previously described.
Receivedfor publication 25 April 1983 acid in revisedform 20June 1983.
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